Alexander Y. Deneka

728 total citations
28 papers, 359 citations indexed

About

Alexander Y. Deneka is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Alexander Y. Deneka has authored 28 papers receiving a total of 359 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Cell Biology. Recurrent topics in Alexander Y. Deneka's work include Peptidase Inhibition and Analysis (7 papers), Ubiquitin and proteasome pathways (6 papers) and Lung Cancer Research Studies (5 papers). Alexander Y. Deneka is often cited by papers focused on Peptidase Inhibition and Analysis (7 papers), Ubiquitin and proteasome pathways (6 papers) and Lung Cancer Research Studies (5 papers). Alexander Y. Deneka collaborates with scholars based in United States, Russia and China. Alexander Y. Deneka's co-authors include Erica A. Golemis, Vladislav A. Korobeynikov, Anna S. Nikonova, Yanis Boumber, Ilya G. Serebriiskii, Meghan C. Kopp, Tim N. Beck, Harvey H. Hensley, Hossein Borghaei and Barbara Burtness and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Alexander Y. Deneka

28 papers receiving 356 citations

Peers

Countries citing papers authored by Alexander Y. Deneka

Since Specialization

Citations

This map shows the geographic impact of Alexander Y. Deneka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Y. Deneka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Y. Deneka more than expected).

Fields of papers citing papers by Alexander Y. Deneka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Y. Deneka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Y. Deneka. The network helps show where Alexander Y. Deneka may publish in the future.

Co-authorship network of co-authors of Alexander Y. Deneka

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Y. Deneka. A scholar is included among the top collaborators of Alexander Y. Deneka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Y. Deneka. Alexander Y. Deneka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Loss of Pkd1 limits susceptibility to colitis and colorectal cancer 2023 ·Oncogenesis ·Anna S. Nikonova, Alexander Y. Deneka, (unknown), (unknown), Rossella Tricarico, Anna A. Kiseleva, Yan Zhou, Émmanuelle Nicolas, Douglas B. Flieder, Sergei I. Grivennikov, Erica A. Golemis	3
2	Association of T P53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer 2022 ·Clinical Cancer Research ·Alexander Y. Deneka, Yasmine Baca, Ilya G. Serebriiskii, Émmanuelle Nicolas, Mitchell I. Parker, (unknown), Joanne Xiu, W. Michael Korn, Michael J. Demeure, Trisha M. Wise‐Draper, Ammar Sukari, Barbara Burtness, Erica A. Golemis	40
3	NEDD9 sustains hexokinase expression to promote glycolysis 2022 ·Oncogenesis ·Alexander Y. Deneka, Anna S. Nikonova, Hyung‐Ok Lee, Warren D. Kruger, Erica A. Golemis	8
4	NEDD9 Restrains dsDNA Damage Response during Non-Small Cell Lung Cancer (NSCLC) Progression 2022 ·Cancers ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Alexander Y. Deneka	5
5	Nedd9 Restrains Autophagy to Limit Growth of Early Stage Non–Small Cell Lung Cancer 2021 ·Cancer Research ·Alexander Y. Deneka, Meghan C. Kopp, Anna S. Nikonova, (unknown), Anna A. Kiseleva, Harvey H. Hensley, Douglas B. Flieder, Ilya G. Serebriiskii, Erica A. Golemis	13
6	Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC) 2021 ·Journal of Thoracic Disease ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Oleg I. Kit, E. M. Frantsiyants, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yanis Boumber, Alexander Y. Deneka	10
7	Prognostic role and biologic features of Musashi-2 expression in colon polyps and during colorectal cancer progression 2021 ·PLoS ONE ·(unknown), (unknown), (unknown), (unknown), (unknown), Alexander Y. Deneka, E. M. Frantsiyants, Oleg I. Kit, Erica A. Golemis, Yanis Boumber	4
8	Evaluation of the Small-molecule BRD4 Degrader CFT-2718 in Small-cell Lung Cancer and Pancreatic Cancer Models 2021 ·Molecular Cancer Therapeutics ·(unknown), Anna S. Nikonova, (unknown), Alexander Y. Deneka, Mark E. Fitzgerald, (unknown), Linda Lee, (unknown), Stewart L. Fisher, Andrew J. Phillips, Christopher G. Nasveschuk, David A. Proia, Zhigang Tu, Erica A. Golemis	9
9	Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies 2021 ·Cancers ·Karam Khaddour, Sushma Jonna, Alexander Y. Deneka, Jyoti D. Patel, Mohamed E. Abazeed, Erica A. Golemis, Hossein Borghaei, Yanis Boumber	44
10	Nedd9 Regulates Metastasis of Non-Small Cell Lung Cancer through Activation of Epithelial-Mesenchymal Transition and Tumor Cells Migration 2020 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Alexander Y. Deneka	3
11	Synthetic Lethal Targeting of Mitotic Checkpoints in HPV-Negative Head and Neck Cancer 2020 ·Cancers ·Alexander Y. Deneka, Margret B. Einarson, John M. Bennett, Anna S. Nikonova, (unknown), Yan Zhou, (unknown), Barbara Burtness, Erica A. Golemis	19
12	Unexpected Activities in Regulating Ciliation Contribute to Off-target Effects of Targeted Drugs 2019 ·Clinical Cancer Research ·Anna A. Kiseleva, Vladislav A. Korobeynikov, Anna S. Nikonova, (unknown), (unknown), Alexander Y. Deneka, Margret B. Einarson, Ilya G. Serebriiskii, Hanqing Liu, Jeffrey R. Peterson, Erica A. Golemis	17
13	An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion 2019 ·BMC Cancer ·Tim N. Beck, Alexander Y. Deneka, (unknown), (unknown), (unknown), Nicolas J. Alvarez, Yanis Boumber, Erica A. Golemis, Glenn W. Laub	5
14	Abstract 1840: Nedd9 controls glycolysis and autophagy in non-small cell lung cancer (NSCLC) 2019 ·Cancer Research ·Alexander Y. Deneka, Anna S. Nikonova, Meghan C. Kopp, (unknown), Anna A. Kiseleva, Harvey H. Hensley, Erica A. Golemis	1
15	Ganetespib limits ciliation and cystogenesis in autosomal‐dominant polycystic kidney disease (ADPKD) 2018 ·The FASEB Journal ·Anna S. Nikonova, Alexander Y. Deneka, Anna A. Kiseleva, Vladislav A. Korobeynikov, (unknown), Ilya G. Serebriiskii, Meghan C. Kopp, Harvey H. Hensley, Tamina Seeger‐Nukpezah, Stefan Somlo, David A. Proia, Erica A. Golemis	30
16	Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model 2017 ·PLoS ONE ·Alexander Y. Deneka, (unknown), Meghan C. Kopp, (unknown), Anna S. Nikonova, Erica A. Golemis	8
17	A Novel HSP90 Inhibitor–Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer 2016 ·Clinical Cancer Research ·(unknown), Anna S. Nikonova, Alexander Y. Deneka, Meghan C. Kopp, Alexander E. Kudinov, (unknown), Vladimir Khazak, Luisa Shin Ogawa, Kathy Q. Cai, Kelly Duncan, James S. Duncan, Brian L. Egleston, David A. Proia, Yanis Boumber, Erica A. Golemis	25
18	Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin 2016 ·Oncotarget ·(unknown), Alexander Y. Deneka, Tim N. Beck, Hanqing Liu, (unknown), Anna S. Nikonova, Émmanuelle Nicolas, Margret B. Einarson, Erica A. Golemis, Ilya G. Serebriiskii	10
19	Embryonal Fyn-associated substrate (EFS) and CASS4: The lesser-known CAS protein family members 2015 ·Gene ·Alexander Y. Deneka, Vladislav A. Korobeynikov, Erica A. Golemis	20
20	Opposing Effects of Inhibitors of Aurora-A and EGFR in Autosomal-Dominant Polycystic Kidney Disease 2015 ·Frontiers in Oncology ·Anna S. Nikonova, Alexander Y. Deneka, (unknown), Meghan C. Kopp, Harvey H. Hensley, Brian L. Egleston, Erica A. Golemis	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact